Pregled bibliografske jedinice broj: 1263413
Liver transplantation in hepatocellular carcinoma – should we perform downstaging?
Liver transplantation in hepatocellular carcinoma – should we perform downstaging? // Croatian Medical Journal, 63 (2022), 4; 317-325 doi:10.3325/cmj.2022.63.317 (recenziran, članak, znanstveni)
CROSBI ID: 1263413 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Liver transplantation in hepatocellular carcinoma –
should we perform downstaging?
Autori
Filipec Kanižaj, Tajana ; Dinjar Kujundžić, Petra ; Ostojić, Ana ; Mijić, Maja ; Sertić Milić, Helga ; Mijić, Ana ; Mateljak, Matija ; Martinčević, Dora ; Radetić, Eva ; Vidjak, Vinko ; Kocman, Branislav ; Mikolašević, Ivana
Izvornik
Croatian Medical Journal (0353-9504) 63
(2022), 4;
317-325
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Liver, Hepatocellular carcinoma, Liver transplantation
Sažetak
Patients successfully downstaged with TACE to the MC can achieve post-LT recipient and HCC recurrence- free survival comparable with patients initially within the MC. Good response to TACE as a criterion for LT may be a method of selecting patients with favorable biological characteristics.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb
Profili:
Vinko Vidjak
(autor)
Helga Sertić Milić
(autor)
Ivana Mikolašević
(autor)
Ana Ostojić
(autor)
Tajana Filipec Kanižaj
(autor)
Anamary Mijić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE